GB1379937A - Preparation of lysine-containing peptides - Google Patents
Preparation of lysine-containing peptidesInfo
- Publication number
- GB1379937A GB1379937A GB5838572A GB5838572A GB1379937A GB 1379937 A GB1379937 A GB 1379937A GB 5838572 A GB5838572 A GB 5838572A GB 5838572 A GB5838572 A GB 5838572A GB 1379937 A GB1379937 A GB 1379937A
- Authority
- GB
- United Kingdom
- Prior art keywords
- lysine
- pyridyl
- prepared
- methoxycarbonyl
- dec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
- C07K1/064—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for omega-amino or -guanidino functions
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21438471A | 1971-12-30 | 1971-12-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1379937A true GB1379937A (en) | 1975-01-08 |
Family
ID=22798896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB5838572A Expired GB1379937A (en) | 1971-12-30 | 1972-12-18 | Preparation of lysine-containing peptides |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3780015A (enExample) |
| JP (1) | JPS5058015A (enExample) |
| CH (1) | CH590824A5 (enExample) |
| DE (1) | DE2264193A1 (enExample) |
| FR (1) | FR2167175A5 (enExample) |
| GB (1) | GB1379937A (enExample) |
| NL (1) | NL7216799A (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4126628A (en) * | 1977-03-28 | 1978-11-21 | Canadian Patents And Development Limited | Acylation of amino acids |
| US5556939A (en) * | 1994-10-13 | 1996-09-17 | Merck Frosst Canada, Inc. | TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications |
| WO2022020711A1 (en) * | 2020-07-24 | 2022-01-27 | The Texas A&M University System | Sars-cov-2 main protease inhibitors |
-
1971
- 1971-12-30 US US00214384A patent/US3780015A/en not_active Expired - Lifetime
-
1972
- 1972-12-11 NL NL7216799A patent/NL7216799A/xx not_active Application Discontinuation
- 1972-12-18 GB GB5838572A patent/GB1379937A/en not_active Expired
- 1972-12-28 CH CH1895772A patent/CH590824A5/xx not_active IP Right Cessation
- 1972-12-28 JP JP48003995A patent/JPS5058015A/ja active Pending
- 1972-12-29 FR FR7246993A patent/FR2167175A5/fr not_active Expired
- 1972-12-29 DE DE2264193A patent/DE2264193A1/de not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US3780015A (en) | 1973-12-18 |
| FR2167175A5 (enExample) | 1973-08-17 |
| CH590824A5 (enExample) | 1977-08-31 |
| NL7216799A (enExample) | 1973-07-03 |
| JPS5058015A (enExample) | 1975-05-20 |
| DE2264193A1 (de) | 1973-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU543198B2 (en) | Hexapeptides | |
| AU544256B2 (en) | Novel acylpeptides | |
| AU531637B2 (en) | Preparation of carboxylic acid amides and peptides | |
| KR840009069A (ko) | 향정신성 펩티드류의 제조 방법 | |
| GB1464630A (en) | Human proinsulin c-peptide derivatives | |
| GB1492252A (en) | Determination of antipyrine | |
| GB1362743A (en) | Nonapeptides and a process for the manufacture thereof | |
| GB1158721A (en) | Peptide synthesis | |
| GB1508682A (en) | Peptide intermediates | |
| AU544742B2 (en) | Prepare amides especially peptides | |
| Greenquist et al. | Chemical evidence for identical subunits in L-asparaginase from Escherichia coli B | |
| GB1393740A (en) | Process for producing activated esters or peptides | |
| Watanabe et al. | Comparative studies on the primary structure of soluble and mitochondrial glutamic oxaloacetic transaminase isozymes.(I) similar peptides isolated by cyanogen bromide cleavage | |
| DE3665462D1 (en) | Pharmacologically active peptides | |
| GB1492255A (en) | Process for the preparation of chloroanthraquinones from nitroanthraquinones | |
| GB1353827A (en) | Acthaction peptides and process for their manufacture | |
| GB1308809A (en) | D-analogs of secretin | |
| GB1346318A (en) | Intermediates for peptide enzyme inhibitors | |
| GB1317028A (en) | Derivatives of secretin | |
| JPS5251093A (en) | Mthod of preparing peptides | |
| EP0326799A3 (de) | Verfahren zur enzymatischen Peptidsynthese | |
| JPS52128291A (en) | Synthesis of peptides | |
| JPS53132539A (en) | Protected amino acid or peptide having said protected amino acid residue | |
| JPS5272883A (en) | Preparation of sulfur-containing amino acid | |
| FR2401906A1 (fr) | Nouveaux sels de paracetamol solubles dans l'eau utiles comme medicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |